Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism IKKβ inhibitors(inhibitor of nuclear factor kappa B kinase subunit beta inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H19BN2O3 |
InChIKeySRYHCTJXUAMMEZ-UHFFFAOYSA-N |
CAS Registry2190477-32-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Preclinical | BR | 16 May 2016 |